LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
- Written by PR Newswire
ANDERNACH, Germany, Dec. 6, 2023 /PRNewswire/ -- LTS, a leading pharmaceutical technology company, announced today that it has received a grant from the Bill & Melinda Gates Foundation. The grant will support new formulation methods for mRNA, such as dissolvable microneedle array patches (MAPs), to increase the thermostability of the...














